Photoelectron X-ray system treats non-brain tumour:
This article was originally published in Clinica
Photelectron's Photon Radiosurgery System has treated its first patient with a gynaecological tumour. The company now plans to develop a protocol for submission to the FDA for an investigational device exemption to start clinical trials using the system in gynaecological tumours. The X-ray delivery system received FDA clearance in June this year for irradiation of intracranial tumours.
You may also be interested in...
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
US FDA Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., CBER’s Marks Says
Timeline is the most pessimistic public projection to date, but still incredibly fast. Clinical trial patients on placebo could be contacted and offered the vaccine after an EUA is granted.